Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Jun. 30, 2019
Jun. 30, 2018
REVENUES:    
Total revenues $ 30,000 $ 149,625
OPERATING COSTS AND EXPENSES    
Professional fees 607,578 449,435
Payroll and related expenses 605,995 602,565
General and administrative 382,615 194,897
Total operating expenses 1,596,188 1,246,897
OPERATING LOSS (1,566,188) (1,097,272)
OTHER EXPENSE    
Interest and other debt expense 54,085 55,104
Loss on debt extinguishment 447,011 0
Total other expense 501,096 55,104
NET LOSS (2,067,284) (1,152,376)
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (860) (6,148)
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. $ (2,066,424) $ (1,146,228)
Basic and diluted loss per common share $ (0.11) $ (0.06)
Weighted average number of common shares outstanding - basic and diluted 19,057,255 17,754,728
Government Contract Revenue [Member]    
REVENUES:    
Total revenues $ 30,000 $ 149,625